Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 689,000 | 745,000 | 698,000 | 827,000 | 1,296,000 |
| Marketable Securities | 159,000 | 172,000 | 185,000 | 129,000 | 344,000 |
| Receivables | 932,000 | 951,000 | 976,000 | 953,000 | 900,000 |
| Inventories | 418,000 | 428,000 | 410,000 | 387,000 | 360,000 |
| Income taxes - deferred | 152,000 | 330,000 | 334,000 | N/A | 241,000 |
| Other current assets | 0 | 135,000 | 112,000 | 461,000 | 0 |
| TOTAL | $2,631,000 | $2,761,000 | $2,715,000 | $2,757,000 | $3,289,000 |
| Non-Current Assets | |||||
| PPE Net | 1,011,000 | 986,000 | 957,000 | 924,000 | 870,000 |
| Investments And Advances | 594,000 | 581,000 | 618,000 | 0 | 529,000 |
| Intangibles | 3,735,000 | 3,532,000 | 3,568,000 | 3,373,000 | 3,340,000 |
| Other Non-Current Assets | 225,000 | 216,000 | 225,000 | 765,000 | 142,000 |
| TOTAL | $5,565,000 | $5,315,000 | $5,368,000 | $5,062,000 | $4,881,000 |
| Total Assets | $8,196,000 | $8,076,000 | $8,083,000 | $7,819,000 | $8,170,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,000 | 84,000 | 538,000 | 430,000 | 502,000 |
| Accounts payable and accrued liabilities | 105,000 | 981,000 | 958,000 | 0 | 108,000 |
| Accrued Expenses | 1,124,000 | N/A | N/A | N/A | 902,000 |
| Other current liabilities | 77,000 | 77,000 | 260,000 | 1,354,000 | 112,000 |
| TOTAL | $1,479,000 | $1,142,000 | $1,756,000 | $1,784,000 | $2,605,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,864,000 | 2,430,000 | 1,518,000 | 1,115,000 | 1,139,000 |
| Other Non-Current Liabilities | 309,000 | 249,000 | 229,000 | 530,000 | 142,000 |
| TOTAL | $2,435,000 | $3,033,000 | $2,110,000 | $1,645,000 | $1,540,000 |
| Total Liabilities | $3,914,000 | $4,175,000 | $3,866,000 | $3,429,000 | $4,145,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 821,567 | 819,484 | 820,188 | 833,149 | 838,757 |
| Common Shares | 8,000 | 8,000 | 8,000 | N/A | 8,000 |
| Retained earnings | 3,410,000 | N/A | N/A | N/A | 2,790,000 |
| Other shareholders' equity | -77,000 | 4,637,000 | 4,935,000 | 4,390,000 | -86,000 |
| TOTAL | $4,282,000 | $3,901,000 | $4,217,000 | $4,390,000 | $4,025,000 |
| Total Liabilities And Equity | $8,196,000 | $8,076,000 | $8,083,000 | $7,819,000 | $8,170,000 |